Science Explorer Back to mapMap
Discussion
Researcher · Marker Gene Technologies (United States) · United States

John Joseph Naleway

John Joseph Naleway publishes mostly in Molecular Biology, Spectroscopy and Organic Chemistry, on topics such as Carbohydrate Chemistry and Synthesis, Lysosomal Storage Disorders Research and Advanced Fluorescence Microscopy Techniques.

ORCID 0000-0002-7038-3807 OpenAlex
World rank
#4,809,449
of 7,710,434 ranked researchers
Rank in United States
#1,259,853
of 1,627,098
Works
30
Citations
487
Citations per work
16.2
h-index
11
i10-index 12Top 71% in Molecular Biology
John Joseph Naleway

What does John Joseph Naleway research?

John Joseph Naleway's work is mostly in Biochemistry, Genetics and Molecular Biology (43%), Chemistry (20%), Engineering (6%).

Life Sciences: 13 works · 42.6% of their workBiochemistry, Genetics and Molecular Biology: 13 works · 42.6% of their workMolecular Biology: 10 works · 34.1% of their workBiophysics: 3 works · 8.5% of their workPhysical Sciences: 8 works · 25.7% of their workChemistry: 6 works · 19.6% of their workOrganic Chemistry: 3 works · 9.8% of their workSpectroscopy: 3 works · 9.8% of their workEngineering: 2 works · 6.1% of their workBiomedical Engineering: 2 works · 6.1% of their workEverything else: 8 works · 25.6% of their workHealth Sciences: 2 works · 6.1% of their workMedicine: 2 works · 6.1% of their workPhysiology: 2 works · 6.1% of their workTHEIR WORKJohn JosephNaleway30works
Life Sciences43%Physical Sciences26%Health Sciences6%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1342.6%
    1. Chemistry619.6%
    2. Engineering26.1%
  3. Everything else825.6%
    1. Medicine26.1%
  1. 1Molecular Biology34% of their works
  2. 2Spectroscopy10% of their works
  3. 3Organic Chemistry10% of their works
  4. 4Biophysics8% of their works
  5. 5Biomedical Engineering6% of their works
  6. 6Physiology6% of their works

Research topics

Which keywords describe John Joseph Naleway's research?

The keywords of their largest research topics: Cancer, Enzyme Replacement Therapy, Glycosidase Inhibitors, Lysosomal Storage Disorders, Oligosaccharide Synthesis, Chiral Separation, Fluorescent Proteins and Liquid Chromatography.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Cancer52 topics
  2. Enzyme Replacement Therapy51 topic
  3. Glycosidase Inhibitors51 topic
  4. Lysosomal Storage Disorders51 topic
  5. Oligosaccharide Synthesis51 topic
  6. Chiral Separation41 topic
  7. Fluorescent Proteins41 topic
  8. Liquid Chromatography41 topic
  9. Super-Resolution Imaging41 topic
  10. Bioimage Analysis31 topic
  11. DNA nanotechnology31 topic
  12. Glycans31 topic
  13. Glycosylation31 topic
  14. High-Content Screening31 topic
  15. Self-Assembly31 topic
  16. Amino Acid Transporters21 topic
  17. D-Serine21 topic

Where does John Joseph Naleway work?

John Joseph Naleway's main affiliation in the publication record is Marker Gene Technologies (United States), United States.

How many publications and citations does John Joseph Naleway have?

OpenAlex counts 30 works and 487 citations for John Joseph Naleway, an h-index of 11, ranking #4,809,449 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about John Joseph Naleway. Posts are plain text and can be reported.